In the 10th edition of our Talking Treatment™ podcast, AZZLY® had the honor of hosting a very esteemed guest: the Honorable Andrea Barthwell, M.D., DFASAM. Dr. Andrea Barthwell is Senior Advisor and Strategist to AZZLY. Dr. Barthwell previously served as…
The COVID-19 pandemic hit many of us hard. The American Rescue Plan Act signed into law this year by the president aims to help U.S. citizens in our recovery from the financial hardships of the last year. The American Rescue…
In October, ABC News reporter Amy Robach brought up Hunter Biden’s issues with substance use in an interview, commenting that he had been “in and out or rehab seven, eight times.” Biden, who is the son of President Joe Biden,…
While money is tight, some behavioral health and addiction treatment center owners might need a little help making payroll and paying rent. We wrote this blog to make you aware of some resources available to you to assist during COVID-19.…
In the United States, crime and drug use are often linked. When the NDIC reports that the cost of drug use is $193 billion annually, for example, that figure heavily factors in not only health fees and premature deaths but…
Effective January 1, 2020, the Centers for Medicare & Medicaid Services (CMS) will pay Opioid Treatment Programs (OTPs) through bundled payments for opioid use disorder (OUD) treatment services in an episode of care provided to people with Medicare Part B…
Opioid overdoses are in decline for the first time in years. Would you know it from looking at your community? In some states—places like Alabama, Connecticut, Kentucky, North Carolina, Ohio, Oklahoma, South Carolina, Tennessee, Nebraska, and West Virginia—Opioid Use Disorder…
Related: Senate Passes Opioid Crisis Response Act – Here's What's in It We wrote in the fall about the U.S. House of Representatives' SUPPORT for Patients and Communities Act, or H.R.6. H.R.6 would go on to become the Opioid Crisis…
In mid-March, the FDA approved the postpartum depression drug brexanolone, providing an option to millions of women who suffer from postpartum depression. Brexanolone is the first federally-approved drug of its kind to be designed specifically to treat postpartum depression. The…
AZZLY joins the Behavioral Health Association of Providers (BHAP) in asking you to support the behavioral health industry by signing this petition. This petition will be delivered to President Trump, the Senate, and the House of Representatives and would urge…
